Antibody, Drug Delivery Systems, Immune Response and Marketing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Antibody

Drug Delivery Systems

Immune Response

Marketing

Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders

Roots Analysis

MARCH 3, 2022

Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. The complement-targeted therapeutics inhibit complement activation, thereby reducing tissue inflammation and dampening the adaptive immune response to foreign and tissue antigens.

Drug Delivery Systems

Drug Delivery Systems Marketing Immune Response Dermatology

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

APRIL 24, 2023

With early nanoparticle studies, researchers often found the human body’s innate immune response to drugs and the short-lasting effects of drugs challenging, as they can also reduce a drug’s efficacy. This design protects antibodies from the innate immune system.

Drug Delivery

Drug Delivery Vaccination Vaccine Research

Clinical Research Informer

Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Stay Connected